Harbour Capital Advisors, LLC Centessa Pharmaceuticals PLC Transaction History
Harbour Capital Advisors, LLC
- $419 Million
- Q4 2024
A detailed history of Harbour Capital Advisors, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Harbour Capital Advisors, LLC holds 16,375 shares of CNTA stock, worth $257,906. This represents 0.07% of its overall portfolio holdings.
Number of Shares
16,375
Previous 16,675
1.8%
Holding current value
$257,906
Previous $266,000
3.01%
% of portfolio
0.07%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$314 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$157 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$152 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$100 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$91.4 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.49B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...